FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Mimvey Lo Recall

Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class II
Reported by FDA
Feb 22, 2017
Recall ID
D-0479-2017
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Mimvey Lo starting Feb 2, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0479-2017 on Feb 22, 2017. Reason: Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.

Product description

Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.

Lot numbers, UPCs & expiration codes

Lot # 33809881A, Exp 05/17; 33811151A, Exp 08/17

Where it was sold

Nationwide in the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0479-2017
Classification
Class II
Status
Terminated
Recall initiated
Feb 2, 2017
FDA report date
Feb 22, 2017
Quantity
17,473 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0479-2017, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
76383
Address
1090 Horsham Rd
Code information
Lot # 33809881A, Exp 05/17; 33811151A, Exp 08/17
Postal code
19454-1505
Report date
Feb 22, 2017
Product type
Drugs
Recall number
D-0479-2017
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
17,473 cartons
Termination date
Feb 6, 2018
Reason for recall
Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.
Distribution pattern
Nationwide in the United States
Recall initiation date
Feb 2, 2017
Initial firm notification
Letter
Center classification date
Feb 16, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0479-2017, published Feb 22, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls